CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 4 Open-market buy Controller/Prin Fin&Acct Offic bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy EVP of Sales & Marketing bought 28,844 shares at $0.52 ($14,999)
- 4 Open-market buy Chief Financial Officer bought 67,306 shares at $0.52 ($34,999)
- 4 Open-market buy Chief R&D Officer bought 7,692 shares at $0.52 ($4,000)
- 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
- 4 Open-market buy Director bought 20,000 shares at $0.52 ($10,400)
- 4 Open-market buy CEO bought 48,076 shares at $0.52 ($25,000)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-K Report Annual Report
Page 20 of 58 · 1,148 filings